Vir Biotechnology, Inc. (NASDAQ:VIR) Q1 2024 Earnings Call Transcript

Operator: Hello. Welcome to Vir Biotechnology’s First Quarter 2024 Financial Results and Business Update Call. As a reminder, this conference call is being recorded.

Related Keywords

United States ,America ,Damouni Ellis ,Gena Wang ,Sasha Damouni Ellis ,Alec Stranahan ,Phil Nadeau ,Norbert Bischofberger ,Paul Choi ,Tsang Lee ,Carrie Huang ,Robert Perez ,Exchange Commission ,Nasdaq ,Corporate Affairs Officer ,World Health Organization Global Hepatitis ,Pfizer ,World Health Organization ,Goldman Sachs ,National Institute Of Allergy ,Study Of The Liver Or Evil Congress ,Barclays ,Vir Biotechnology Inc ,Clinical Research ,Vir Biotechnology ,Call Transcript May ,First Quarter ,Business Update ,Executive Vice President ,Chief Corporate Affairs ,Marianne De Backer ,Chief Executive Officer ,Senior Vice President ,Interim Chief Medical Officer ,Sung Lee ,Chief Financial ,Doctor Norbert Bischofberger ,Doctor Farid ,Doctor Philip Sharp ,Chief Financial Officer ,Devil Congress ,World Health Organization Global Hepatitis Report ,National Institute ,Infectious Diseases ,Billemanenda Gates ,Med Archives ,Highest Consumer Spending ,